Investor Resources. Back; FAQ · Information Requests · IR Contact. Investor Relations. Corporate Profile. Lantheus provides innovative diagnostics, targeted ...
Missing: pgnx | Show results with:pgnx
Feb 20, 2020 · PGNX. The Nasdaq stock Market. Indicate by ... If such Progenics stock option is an in-the-money Progenics stock ... Investor Relations at Progenics ...
Contact: Investors: Amy Martini Corporate Affairs (914) 789-2816 amartini@progenics. 2011-09-15, EX-99.1. PROGENICS PHARMACEUTICALS ANNOUNCES STRATEGIC FOCUS ON ...
NASDAQ | LNTH (Common Stock). Data provided by Nasdaq. Minimum 15 minutes delayed. Visit Investor Site. Receive Email Alerts. Join us to change lives. Looking ...
Oct 2, 2019 · Source: Lantheus Holdings, Inc. and Progenics Pharmaceuticals, Inc. Lantheus Holdings Investor Contact: Mark Kinarney 978-671-8001 ir@lantheus.
progenics pharmaceuticals announces fourth quarter and full ...
www.sec.gov › data › prog20200311_425
(Nasdaq:PGNX) today announced financial results ... Investor Relations at Lantheus Holdings or Progenics as described above. ... Information on or accessed through ...
The Investor Relations website contains information about MacroGenics, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: pgnx | Show results with:pgnx
Jun 20, 2017 · The following slide deck was published by Progenics Pharmaceuticals Inc.
Missing: relations | Show results with:relations
Jun 22, 2020 · Investor Resources. Back; FAQ · Information Requests ... (“Progenics”) (Nasdaq: PGNX), an oncology ... Senior Director, Investor Relations 978-671 ...
People also ask
What happened to Progenics Pharmaceuticals?
Who owns progenics?
Where is Lantheus located?
Who owns Pylarify?
Company's Online Information Links. HOME PAGE: https://www.progenics.com/. Company's Investor Relations Information, Goto Investor Relations Information.